American Vanguard Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVD research report →
Range $14 – $20
Price Chart
About the company
American Vanguard Corporation, through its various subsidiaries, develops, manufactures, and markets a diverse portfolio of specialized chemicals for agricultural, commercial, and consumer applications across the United States and internationally. The company formulates and produces a comprehensive range of chemicals, including pest control agents like insecticides, fungicides, herbicides, and molluscicides, as well as solutions for soil health, plant nutrition, growth regulation, and soil fumigation. These offerings are available in liquid, powder, and granular forms, serving purposes in crop cultivation, turf and ornamental plant management, and human and animal health protection.
- CEO
- Douglas A. Kaye
- IPO
- 1987
- Employees
- 739
- HQ
- Newport Beach, CA, US
Get TickerSpark's AI analysis on AVD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $50.06M
- P/E
- -0.93
- Fwd P/E
- 4.61
- PEG
- -0.02
- P/S
- 0.10
- P/B
- 0.28
- EV/EBITDA
- -26.40
- Div Yield
- 0.00%
- Gross Margin
- 29.38%
- Op Margin
- 0.74%
- Net Margin
- -10.70%
- ROE
- -27.84%
- ROIC
- 0.80%
Latest fiscal year · YoY change
- Revenue
- $515.11M-5.9%
- Gross Profit
- $147.56M+22.6%
- Op Income
- $13.77M
- Net Income
- $-49,882,000+60.5%
- EPS
- $-1.75+61.1%
- OCF Growth
- -640.2%
- FCF Growth
- -571.3%
- 52W High
- $5.55
- 52W Low
- $1.67
- 50D MA
- $2.20
- 200D MA
- $3.12
- Beta
- 1.44
- RSI (14)
- 29
- Avg Volume
- 264.35K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
American Vanguard said Q2 sales fell and EBITDA slumped on weak international demand and freight costs, but it sees margin recovery, Q3 carryover orders, and full-year guidance unchanged.· August 10, 2026
- Q2 sales were $117 million versus $129 million a year ago; first-half sales were $240 million, down about 2% from $245 million.
- Gross margin was 30% in Q2 versus 31% last year; first-half gross margin improved to 30% from 29%.
- Adjusted EBITDA fell to $600 thousand from $11 million in Q2 2025, but first-half adjusted EBITDA rose to $17 million from $14 million.
- US specialty and herbicide demand remained strong, while international sales fell 18% in the quarter and 13% for the first half.
- Management kept 2026 guidance at $44 million to $48 million of adjusted EBITDA on sales of $530 million to $550 million.
Second-quarter sales were $117 million, down from $129 million in the same quarter of 2025. First-half sales were $240 million versus $245 million last year. Q2 gross margin was 30% versus 31% a year ago, while first-half gross margin improved to 30% from 29%. Adjusted EBITDA was $600 thousand in Q2, down from $11 million last year, but first-half adjusted EBITDA increased to $17 million from $14 million. Management reiterated full-year 2026 adjusted EBITDA guidance of $44 million to $48 million on sales of $530 million to $550 million. The company also said it expects the LA plant rationalization to save at least $4 million annually and expects pricing actions to help offset freight costs in the second half of 2026.
Dak Kaye framed the quarter as evidence that the company is outperforming peers in the US despite a difficult ag environment. He emphasized three priorities: lowering costs, improving commercial execution, and investing in new products, including a target of 50 launches over five years and $100 million in annualized revenue by 2030. His tone was constructive but cautious, repeatedly stressing that the second half of 2026 is important and that the external environment remains weak.
David T. Johnson highlighted the Q2 sales decline, with US crop sales down 9% and international sales down 18%, while specialty sales grew 11% in the quarter and 10% for the first half. He pointed to roughly $2 million of freight cost impact in Q2 and said weaker factory absorption also hurt margins, but noted first-half gross margin still improved 100 basis points to 30%. He said cash ended the quarter at $43.9 million, debt was $267.6 million, net debt was $224.7 million, and inventories were $181 million versus $191 million a year ago, reflecting tighter working capital discipline.
Analysts focused on pricing pressure in Latin America, the visibility of the order book, and the meaning of the company’s 2028 targets. Management said it is seeing pricing increases rather than decreases, especially in Brazil where copper costs are driving higher prices, and also in freight-related pricing that began to take hold in July. On visibility, Kaye said shipment delays rolled into Q3 and the Q3 order book looks better than last year, supporting confidence in the full-year forecast. On the 2028 target, he clarified the $600 million revenue goal is an annualized run rate by the back half of 2028, with double-digit EBITDA as the goal, while acknowledging the ag cycle will matter.
The bull case is that US businesses are holding up better than the broader market, especially specialty and herbicides, which posted 11% quarterly growth. Management also believes pricing actions should help recover freight inflation, and it expects cost savings from plant rationalization and headquarters relocation to flow through in the second half. The company kept full-year guidance intact and said the Q3 order book looks healthy.
The bear case is that the quarter showed clear pressure from weak international demand, cautious grower spending, and timing shifts that pushed cotton sales into Q3. Freight costs hurt margins by about $2 million in the quarter, adjusted EBITDA was only $600 thousand, and net debt rose to $224.7 million from $194.7 million sequentially due to seasonal working capital needs. Management also acknowledged the agricultural downturn may linger through 2027-2028, making the path to the 2028 targets dependent on either a market recovery or continued internal execution.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 96.4%
- Shares Outstanding
- 28.61M
- Float Shares
- 27.58M
of shares held by institutions
118 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Wellington Management Group Llp | 1.72M | ▲ 68.11K |
| Vanguard Group Inc | 1.55M | ▲ 7.20K |
| Cove Street Capital, LLC | 1.40M | ▲ 150.70K |
| Vanguard Capital Management LLC | 1.15M | ▲ 7.27K |
| Blackrock, Inc. | 933.47K | ▼ 1.15M |
| Evr Research LP | 775.00K | ▲ 55.00K |
| Dimensional Fund Advisors LP | 774.60K | ▼ 270.21K |
| Two Sigma Investments, LP | 732.82K | ▼ 13.37K |
| Cruiser Capital Advisors, LLC | 571.78K | 0 |
| D. E. Shaw & Co., Inc. | 530.01K | ▲ 26 |
| Castleknight Management LP | 504.33K | 0 |
| Rbf Capital, LLC | 418.58K | ▲ 418.58K |
Held by 56 ETFs
Biggest fund positions in AVD by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 18, 26 | ROSENBLOOM KEITH M | sell | 556,580 |
| Aug 17, 26 | Macicek Steven D | buy | 19,000 |
| Jul 10, 26 | Kaye Douglas | other | 6,527 |
| Jun 4, 26 | ROSENBLOOM KEITH M | other | 31,872 |
| Jun 4, 26 | Johnson David` T. | other | 20,000 |
| Jun 4, 26 | Kaye Douglas | other | 50,000 |
| Jun 3, 26 | Kaye Douglas | buy | 5,000 |
| Jun 4, 26 | McDougal Rubin J | other | 31,872 |
| Jun 4, 26 | McDougal Rubin J | other | 0 |
| Jun 4, 26 | DiPaola Michael Joseph | other | 20,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AVD coverage
Recent articles, reports, and earnings notes.
No research on AVD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AVD report →American Vanguard Corporation (AVD) Announces CFO Transition
accessnewswire.com · Oct 1
American Vanguard Announces Acquisition of U.S. Crop-Protection Products from Syngenta
accessnewswire.com · Sep 29
American Vanguard Corporation (AVD) Announces Executive Appointment of Mark Helt as U.S. Crop President
accessnewswire.com · Aug 11
American Vanguard Q2 Earnings Call Highlights
marketbeat.com · Aug 10
American Vanguard Corporation (AVD) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 10
American Vanguard Reports Second Quarter 2026 Results
accessnewswire.com · Aug 10
American Vanguard Corporation (AVD) Announces Executive Appointment of Hermann Castro as Senior Vice President, Marketing and Business Development at AMVAC
accessnewswire.com · Jul 1
American Vanguard Announces Voting Results Of 2026 Annual Meeting Of Stockholders
accessnewswire.com · Jun 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.